Drug Repurposing for Cancer Therapy
Carlos M. Telleria*
Division of Basic Biomedical Sciences, Sanford School of Medicine of The University of South Dakota, 414 East Clark Street, Vermillion, SD 57069, USA
- *Corresponding Author:
- Carlos M. Telleria
Division of Basic Biomedical Sciences
Sanford School of Medicine of The University of South Dakota
414 East Clark Street, Vermillion, SD 57069, USA
E-mail: [email protected]
Received Date: July 19, 2012; Accepted Date: July 21, 2012; Published Date: July 21, 2012
Citation: Telleria CM (2012) Drug Repurposing for Cancer Therapy. J Cancer Sci Ther 4: ix-xi. doi: 10.4172/1948-5956.1000e108>
Copyright: © 2012 Telleria CM. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Clinicians should develop new hypotheses based on observations and interviews with patients, and basic researchers should go back to the bench to test compounds with anticipated anti-growth properties. Let’s not forget that the most popularly used anticancer agent, platinum, was discovered serendipitously when microbiologists were investigating the behavior of bacteria upon changes in voltage and observed growth inhibition due to electrolysis products from a platinum electrode. Hopefully, using all these resources, we will convert cancer into a treatable chronic disease. The current technological armamentarium provides cancer researchers with a unique opportunity to find new targets for old synthetic, abandoned compounds or newly discovered natural products.